Patent details
EP3773589
Title:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
Basic Information
- Publication number:
- EP3773589
- PCT Application Number:
- US2019025655
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP197185317
- PCT Publication Number:
- WO2019195471
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
- French Title of Invention:
- INHIBITEUR DE RET DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU CANCER PRÉSENTANT UNE ALTÉRATION DU RET
- German Title of Invention:
- RET-INHIBITOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS MIT EINER RET-VERÄNDERUNG
- SPC Number:
-
Dates
- Filing date:
- 03/04/2019
- Grant date:
- 01/11/2023
- EP Publication Date:
- 17/02/2021
- PCT Publication Date:
- 10/10/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/11/2023
- EP B1 Publication Date:
- 01/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/04/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/10/2023
-
-
- Name:
- Blueprint Medicines Corporation
- Address:
- 45 Sidney Street, Cambridge, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 18/01/2024
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- WOLF, Beni B.
- Address:
- United States (US)
2
- Name:
- EVANS RAAB, Erica
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862652284 P
- Priority Date:
- 03/04/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201862656297 P
- Priority Date:
- 11/04/2018
- Priority Country:
- United States (US)
3
- Priority Number:
- 201862657605 P
- Priority Date:
- 13/04/2018
- Priority Country:
- United States (US)
4
- Priority Number:
- 201862741683 P
- Priority Date:
- 05/10/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/506;
A61K 45/06;
A61P 35/04;
A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202344
- Publication date:
- 01/11/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 26/03/2025
- Last Annual Fee Paid Number:
- 7
- Last Annual Fee Paid Amount:
- 82 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM